Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMirriad Advertising Regulatory News (MIRI)

  • This share is currently suspended. It was suspended at a price of 0.0024

Share Price Information for Mirriad Advertising (MIRI)

Share Price is delayed by 15 minutes
Get Live Data
0.0024    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: £409.74k
MIRI Live PriceLast checked at - London Stock Exchange

Intraday Mirriad Advertising Share Chart

Corporate Update

23 Apr 2026 07:00

RNS Number : 5579B
Mirriad Advertising PLC
23 April 2026
 

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014 4 as it forms part of UK domestic law pursuant to the Market Abuse (Amendment) (EU Exit) regulations (SI 2019/310) ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain

 

23 April 2026

 

Mirriad Advertising plc

("Mirriad" or the "Company")

 

Corporate Update

 

Mirriad Advertising plc (AIM: MIRI), a leading virtual in-content advertising and virtual product placement company, provides the following update.

2026 has proven to be an exceptionally challenging year for Mirriad. The Company's cautious optimism at the start of the year, which was as a result of Mirriad's partners' guidance of their expectations for advertising spend, has not been realised.

 

Trading conditions deteriorated significantly following a rapid escalation in geopolitical tensions during a critical period for the business, most notably the conflict in Iran impacting the key Middle Eastern market. This coincided with the Company's projected busiest seasonal period and resulted in a sustained reduction in advertising spend, from which activity levels have not recovered.

 

Efforts to diversify revenue streams and accelerate opportunities in other regions have progressed, but at a slower pace than required to offset these headwinds and the Company's current funding constraints. Performance from Mirriad's US joint venture partner has also been significantly below expectations, adding further pressure to the Company's financial position.

 

In May 2025, the Company implemented significant cost‑reduction measures to preserve liquidity while continuing to deliver its core product offering. These actions materially reduced the cost base and enabled Mirriad to maintain essential operations and progress elements of its technology roadmap, albeit within a substantially leaner structure.

 

On 30 March 2026, the Company announced that it had cash equivalents of circa £675k and that it would be required to secure further funding prior to the publication of its annual report and accounts for the year ended 31 December 2025. The directors of Mirriad ("Directors") have been exploring a range of funding options; however, to date no binding funding has been secured. The Company's current cost base is approximately £220k per month.

 

In light of the above, and in the absence of an immediate injection of capital, the Directors recognise that they must consider the interests of creditors. Accordingly, the Directors expect that they may have to commence the process of placing the Company or its operating subsidiaries into either a liquidation process or an administration process in the near term in order to effect an orderly wind down. Should this occur, it is anticipated that trading in the Company's shares would be suspended.

 

Further announcements will be made in due course.

 

ENDS

 

For further information please visit www.mirriad.com or contact:

 

Mirriad Advertising plc

Louis Wakefield, Chief Executive Officer

James Black, Chairman

 

 

 

c/o Allenby

Allenby Capital Limited (Nominated Adviser and Broker)

James Reeve (Corporate Finance)

Matt Butlin / Lauren Wright (Sales and Corporate Broking)

 

 

 

Tel: +44 (0)20 3328 5656

 

 

About Mirriad

The leader in virtual product placement and in-content advertising, Mirriad's multi-patented and award-winning platform can dynamically insert products and brands into Television, SVOD/AVOD, Music, and Influencer content. Mirriad creates net-new revenue opportunities for content owners with an ad format that virtually integrates brands in entertainment content, drives exceptional performance for advertisers and dramatically improves the viewing experience.

 

Mirriad currently operates in: EMEA, the US (via a Joint Venture with Rembrand), and India.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDDLLFLQZLBBBD
Date   Source Headline
21st Apr 202111:00 amRNSPrice Monitoring Extension
21st Apr 20217:00 amRNSMirriad upgrades to New York OTCQX® Best Market
15th Apr 20217:00 amRNSNotice of analyst and investor webinar
24th Feb 20211:51 pmRNSBoard Appointment
2nd Feb 202112:14 pmRNSAppointment of Chief Technology Officer
6th Jan 202111:34 amRNSHolding(s) in Company
22nd Dec 20206:02 pmRNSPDMR Dealings Correction
22nd Dec 20205:12 pmRNSPDMR Dealings
15th Dec 20202:56 pmRNSResult of General Meeting and Open Offer
27th Nov 20206:10 pmRNSPosting of Circular
27th Nov 20202:05 pmRNSSecond Price Monitoring Extn
27th Nov 20202:00 pmRNSPrice Monitoring Extension
27th Nov 20207:00 amRNSResults of Accelerated Bookbuild
26th Nov 20204:35 pmRNSProposed Conditional Placing and Open Offer
9th Nov 20207:00 amRNSMirriad launches music alliance
28th Oct 20207:00 amRNSMirriad Signs Contract With Tier One Media Giant
30th Sep 202010:28 amRNSHolding(s) in Company
29th Sep 20201:36 pmRNSHolding(s) in Company
28th Sep 20204:25 pmRNSIssue of Equity
23rd Sep 20207:09 amRNSPrice Monitoring Extension
23rd Sep 20207:02 amRNSSecond Price Monitoring Extn
22nd Sep 20202:06 pmRNSSecond Price Monitoring Extn
22nd Sep 20202:00 pmRNSPrice Monitoring Extension
14th Sep 20202:05 pmRNSSecond Price Monitoring Extn
14th Sep 20202:00 pmRNSPrice Monitoring Extension
10th Sep 20207:00 amRNSInterim results
9th Sep 20207:00 amRNSOTC listing
26th Aug 20207:00 amRNSNotice of interim results and webinar
12th Aug 20204:41 pmRNSSecond Price Monitoring Extn
12th Aug 20204:36 pmRNSPrice Monitoring Extension
16th Jun 20207:00 amRNSApproval of resolutions at AGM
10th Jun 20204:41 pmRNSSecond Price Monitoring Extn
10th Jun 20204:36 pmRNSPrice Monitoring Extension
28th May 20204:41 pmRNSSecond Price Monitoring Extn
28th May 20204:36 pmRNSPrice Monitoring Extension
20th May 20207:00 amRNSAnnual Report and Accounts and Notice of AGM
18th May 20202:34 pmRNSExecutive LTIP award, Director and PDMR dealings
13th May 20202:33 pmRNSHolding(s) in Company
12th May 20207:00 amRNSResults for the year ended 31 December 2019
11th May 20204:41 pmRNSSecond Price Monitoring Extn
11th May 20204:36 pmRNSPrice Monitoring Extension
7th May 20201:48 pmRNSMirriad sees returning Chinese consumer confidence
6th May 20202:45 pmRNSNotice of analyst and investor webinar
2nd Apr 20207:00 amRNSDirector dealing
19th Mar 20207:00 amRNSMarket Update
5th Mar 20207:00 amRNSCorporate Broker Appointment
5th Feb 20207:00 amRNSYear-end trading update
17th Dec 20197:00 amRNSMirriad technology showcase and newsletter
22nd Oct 20194:00 pmRNSHolding(s) in Company
22nd Oct 20194:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.